Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 442,770Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 20MYLAN IRELAND LTD

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 7491736

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 7521041

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 10106503

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 10343995

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

05

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 11484531

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-10-23

blank

06

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 12048692

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2039-08-29

blank

07

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 8053448

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

08

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 7585879

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-03-10

blank

09

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 11008289

Drug Substance Claim :

Drug Product Claim :

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank

10

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

REVEFENACIN

US Patent Number : 11858898

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 210598

Patent Use Code : U-2440

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2030-07-14

blank